---
title: "Xingqi Pharmaceutical: The first subject has been enrolled in the Phase II clinical trial of Voriconazole eye drops"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252628765.md"
description: "According to the Zhitong Finance APP, Xingqi Pharmaceutical announced that the company's developed voriconazole eye drops completed the enrollment of the first subject today, officially entering Phase II clinical trials. The Phase II clinical trial study of voriconazole eye drops is a randomized, positive-controlled, multi-center exploratory trial aimed at preliminarily exploring the efficacy and safety of voriconazole eye drops in subjects with fungal keratitis, in order to explore safe and effective drug concentrations for Phase III clinical trials"
datetime: "2025-08-12T08:41:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252628765.md)
  - [en](https://longbridge.com/en/news/252628765.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252628765.md)
generator: "portal-rs"
---

# Xingqi Pharmaceutical: The first subject has been enrolled in the Phase II clinical trial of Voriconazole eye drops

According to the Zhitong Finance APP, Xingqi Pharmaceutical (300573.SZ) announced that the company's developed voriconazole eye drops completed the enrollment of the first subject today, officially entering Phase II clinical trials.

The Phase II clinical trial study of voriconazole eye drops is a randomized, positive-controlled, multi-center exploratory trial aimed at initially exploring the efficacy and safety of voriconazole eye drops in subjects with fungal keratitis, to explore safe and effective drug concentrations for Phase III clinical trials

### Related Stocks

- [300573.CN](https://longbridge.com/en/quote/300573.CN.md)

## Related News & Research

- [Happen SVP, Corporate Controller Fergal Stack disposes of common shares worth $2.15 million](https://longbridge.com/en/news/296547158.md)
- [Great Western Mining Corporation plc Announces Holding(s) in Company | GWMOF Stock News](https://longbridge.com/en/news/296442037.md)
- [SBG: Stable revenue but lower profitability in Q2 2026; strong cash flow and focus on AI commercialization](https://longbridge.com/en/news/296576236.md)
- [Wu Wei Appointed Vice Chairman and General Manager of CIC](https://longbridge.com/en/news/296582877.md)
- [TGN: Net profit fell 51% year-over-year, but market cap reached a record high amid major investments](https://longbridge.com/en/news/296490198.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**